Terug
18
Dagbereik
€ 69,98
€ 72,00
52-Weeksbereik
€ 61,78
€ 89,83
Volume
1.568.138
50D / 200D Gem.
€ 80,00
/
€ 74,62
Vorige Slotkoers
€ 70,49
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 37,2 | 0,2 |
| P/B | 1,7 | 3,0 |
| ROE % | 4,6 | 3,6 |
| Net Margin % | 9,2 | 3,8 |
| Rev Growth 5Y % | 8,8 | 10,0 |
| D/E | 0,3 | 0,2 |
Koersdoel Analisten
Hold
€ 93,86
+31.4%
Low: € 73,00
High: € 100,00
Forward K/W
15,26
Forward WPA
€ 4,62
WPA Groei (sch.)
+0,0%
Omzet Sch.
4,32B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 5,96
€ 5,90 – € 6,02
|
5,03B | 2 |
| FY2028 |
€ 5,45
€ 4,89 – € 6,18
|
4,79B | 6 |
| FY2027 |
€ 5,03
€ 4,88 – € 5,11
|
4,55B | 12 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-03-05 | € 1,10 | € 1,10 | 0,0% |
| 2025-12-04 | € 1,11 | € 1,15 | +3,6% |
| 2025-08-27 | € 1,07 | € 1,10 | +2,8% |
| 2025-05-29 | € 0,93 | € 0,96 | +3,4% |
| 2025-03-06 | € 0,91 | € 0,92 | +0,7% |
| 2024-12-05 | € 1,00 | € 1,04 | +4,0% |
| 2024-08-28 | € 0,91 | € 0,96 | +5,4% |
| 2024-05-30 | € 0,83 | € 0,85 | +2,5% |
Dividend History
5 yr streakYield
0,00%
Payout Ratio
0,00%
Growth (3Y)
0,00%
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Jul 26, 2023 | Aug 11, 2023 | € 0,03 | 0,02% |
| Jan 20, 2023 | Feb 10, 2023 | € 0,03 | 0,02% |
| Jul 26, 2022 | Aug 11, 2022 | € 0,03 | 0,02% |
| Jan 20, 2022 | Feb 09, 2022 | € 0,03 | 0,02% |
| Jul 26, 2021 | Aug 11, 2021 | € 0,03 | 0,01% |
| Jan 21, 2021 | Feb 09, 2021 | € 0,03 | 0,02% |
| Jul 22, 2020 | Aug 07, 2020 | € 0,03 | 0,02% |
| Jan 22, 2020 | Feb 10, 2020 | € 0,03 | 0,02% |
| Jul 22, 2019 | Aug 07, 2019 | € 0,03 | 0,02% |
| Jan 18, 2019 | Feb 08, 2019 | € 0,03 | 0,02% |
| Jul 20, 2018 | Aug 07, 2018 | € 0,03 | 0,02% |
| Jan 22, 2018 | Feb 09, 2018 | € 0,03 | 0,02% |
| Jul 19, 2017 | Aug 07, 2017 | € 0,03 | 0,02% |
| Jan 19, 2017 | Feb 09, 2017 | € 0,03 | 0,03% |
| Jul 20, 2016 | Aug 05, 2016 | € 0,03 | 0,03% |
| Jan 20, 2016 | Feb 09, 2016 | € 0,03 | 0,05% |
| Jul 22, 2015 | Aug 06, 2015 | € 0,03 | 0,03% |
| Jan 21, 2015 | Feb 09, 2015 | € 0,03 | 0,04% |
| Jul 22, 2014 | Aug 06, 2014 | € 0,03 | 0,04% |
| Jan 22, 2014 | Feb 07, 2014 | € 0,03 | 0,05% |
Belangrijkste Punten
Revenue grew 8,78% annually over 5 years — modest growth
ROE of 4,59% is below average
Debt/Equity of 0,34 — conservative balance sheet
Generating 433,70M in free cash flow
P/E of 37,19 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,72%
Groei
Revenue Growth (5Y)
8,78%
Revenue (1Y)5,06%
Earnings (1Y)-4,44%
FCF Growth (3Y)42,03%
Kwaliteit
Return on Equity
4,59%
ROIC4,65%
Net Margin9,16%
Op. Margin16,69%
Veiligheid
Debt / Equity
0,34
Current Ratio1,89
Interest Coverage6,83
Waardering
P/E Ratio
37,19
Forward P/E15,26
P/B Ratio1,69
EV/EBITDA24,33
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,06% | Revenue Growth (3Y) | 6,72% |
| Earnings Growth (1Y) | -4,44% | Earnings Growth (3Y) | 12,89% |
| Revenue Growth (5Y) | 8,78% | Earnings Growth (5Y) | -40,27% |
| Profitability | |||
| Revenue (TTM) | 4,09B | Net Income (TTM) | 374,90M |
| ROE | 4,59% | ROA | 3,02% |
| Gross Margin | 60,67% | Operating Margin | 16,69% |
| Net Margin | 9,16% | Free Cash Flow (TTM) | 433,70M |
| ROIC | 4,65% | FCF Growth (3Y) | 42,03% |
| Safety | |||
| Debt / Equity | 0,34 | Current Ratio | 1,89 |
| Interest Coverage | 6,83 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | 0,00% | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 5 yrs | ||
| Valuation | |||
| P/E Ratio | 37,19 | Forward P/E | 15,26 |
| P/B Ratio | 1,69 | P/S Ratio | 3,41 |
| PEG Ratio | -8,16 | Forward PEG | N/A |
| EV/EBITDA | 24,33 | Fwd EV/EBITDA | 14,49 |
| Forward P/S | 3,23 | Fwd Earnings Yield | 6,55% |
| FCF Yield | 3,11% | ||
| Market Cap | 13,94B | Enterprise Value | 16,61B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,09B | 3,90B | 3,59B | 3,31B | 2,92B |
| Net Income | 374,90M | 392,30M | 294,20M | 385,80M | 2,94B |
| EPS (Diluted) | 1,87 | 1,96 | 1,48 | 1,94 | 59,07 |
| Gross Profit | 2,48B | 2,60B | 2,36B | 2,14B | 1,96B |
| Operating Income | 682,90M | 705,70M | 533,10M | 507,60M | 505,80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12,39B | 12,32B | 11,66B | 11,49B | 9,61B |
| Total Liabilities | 4,16B | 4,23B | 4,11B | 4,32B | 2,66B |
| Shareholders' Equity | 8,24B | 8,08B | 7,55B | 7,17B | 6,94B |
| Total Debt | 2,78B | 2,58B | 2,57B | 2,76B | 1,48B |
| Cash & Equivalents | 110,60M | 107,60M | 120,80M | 138,20M | 95,90M |
| Current Assets | 2,11B | 1,95B | 1,70B | 1,53B | 1,47B |
| Current Liabilities | 1,11B | 1,02B | 969,00M | 1,28B | 732,10M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#1000 of 1049
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026